Lenvima 4mg Capsule (Lenvatinib)

Lenvima 4mg Capsule is a targeted therapy-based anticancer medicine. It is used in the treatment of various types of cancer, including differentiated thyroid cancer, liver cancer, kidney cancer, and endometrial cancer. It contains Lenvatinib as an active ingredient that belongs to the tyrosine kinase inhibitor (TKI) class of drugs. It works by blocking the action of a specific protein to stop the growth and multiplication of cancer cells and the formation of new blood vessels. Lenvatinib 4mg capsule is used in differentiated thyroid cancer that is no longer responsive to radioactive iodine therapy and advanced renal cell carcinoma in combination therapy.

The capsule must be taken orally and swallowed whole with water and should not be crushed, chewed, or opened. The prescribed dose and duration of the Lenvatinib 4mg capsule depend on the patient's condition and response to treatment. It can also be taken with or without food. Patients are advised not to change the dosage and timings prescribed by the doctors because it can cause severe side effects.

Common side effects include tiredness, decreased appetite, nausea, vomiting, diarrhea, weight loss, mouth sores, headache, high blood pressure, and changes in thyroid function. A few patients can undergo severe side effects, including severe chest pain, difficulty breathing, severe headache or confusion, significant bleeding and severe abdominal pain. Most of the Lenvatinib 4mg capsule side effects can leave when the body adapts to the medicine. However, if any side effects persist, inform your doctor immediately.

Women who can become pregnant should use effective contraception during the treatment. Patients must list all medicines, supplements, and herbal products that they are taking. The Lenvatinib 4mg capsule must be used under medical oversight or medical supervision only. Attend regular tests and follow-ups to monitor the medicine response and reduce side effects. Before making any adjustments, changing the dose, or stopping the treatment, consult with your doctor to maximize the benefit.

Kidney, Thyroid, and Liver cancer

The human body shows undesired symptoms after taking Lenvatinib 4mg Capsule (Lenvima). Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Some of the common side effects of Lenvima Capsule are mentioned below:
● Nausea
● Fatigue
● Diarrhea
● Vomiting
● Headache
● Weight loss
● Loss of appetite
● Changes in taste
● Joint pain or muscle pain
● Stomach pain or discomfort
● Hypertension (high blood pressure)

Lenvatinib 4mg Capsule (Lenvima) is a prescription-based anticancer drug that should be administered orally. Lenvima is taken orally with or without food as per the doctor's advice.

It is consumed at the same time each day for better results. It is recommended not to crush, chew, or split the capsule, take it as a whole.

● Študentová, H., Vitásková, D., & Melichar, B. (2018). Lenvatinib for the treatment of kidney cancer. Expert Review of Anticancer Therapy, 18(6), 511-518.
● Suyama, K., & Iwase, H. (2018). Lenvatinib: a promising molecular targeted agent for multiple cancers. Cancer control, 25(1), 1073274818789361.
● Taylor, M. H., Lee, C. H., Makker, V., Rasco, D., Dutcus, C. E., Wu, J., ... & Motzer, R. J. (2020). Phase IB/II trial of lenvatinib plus pembrolizumab in patients with advanced renal cell carcinoma, endometrial cancer, and other selected advanced solid tumors. Journal of Clinical Oncology, 38(11), 1154-1163.
● Krajewska, J., Kukulska, A., & Jarzab, B. (2015). Drug safety evaluation of lenvatinib for thyroid cancer. Expert Opinion on Drug Safety, 14(12), 1935-1943.
● Cabanillas, M. E., & Habra, M. A. (2016). Lenvatinib: Role in thyroid cancer and other solid tumors. Cancer treatment reviews, 42, 47-55.